GGrantIndex
Sort

59,101 grants matching hypertension

Pioglitazone & Exercise Effects on Older Aldults with MCI and Metabolic Syndrome

$496,128
Robert S Schwartz · University Of Colorado Denver · R01 · FY2010 · AG

Viper Resource Center (VRC) at Texas A&M University-Kingsville (TAMUK)

$496,118
Elda E. Sanchez · Texas A&M University-Kingsville · P40 · FY2015 · OD

DECONSTRUCTING INFLAMMATION AND ALTERED MICROBIOTA IN METABOLIC SYNDROME

$496,103
Andrew T Gewirtz · Georgia State University · R01 · FY2023 · DK

Oncogenic Met Signaling in Urologic Malignancies

$496,098
Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Hyperglycemia, Hearing Loss and Vestibular Dysfunction: The CARDIA Study

$496,041
Pamela J Schreiner · University Of Minnesota · R01 · FY2020 · DC

ASSESSMENT OF MEDHERENT MEDICATION MANAGEMENT DEVICE AND ADHERENCE PLATFORM

$496,039
Joel F Feldman · Terrapin Pharmacy · R44 · FY2020 · MH

Promoting stretching exercise to reduce cardiovascular health risk in late pregnant women with obesity

$496,035
Seonae Yeo · Univ Of North Carolina Chapel Hill · R01 · FY2019 · NR

Interdisciplinary Training Program in Cardiovascular Disease

$496,003
Dudley K. Strickland · University Of Maryland Baltimore · T32 · FY2016 · HL

iPPSIS: implanted Passive Pressure Sensor Interrogated with (ultra)-Sound

$495,977
David Richard Myers · Emory University · R01 · FY2024 · EB

Studies on the Structure of Basement Membranes

$495,963
Billy Gerald Hudson · Vanderbilt University · R37 · FY2007 · DK

PA SPREAD: Spreading Quality Improvement Infrastructure across Pennsylvania

$495,954
Alan M. Adelman · Pennsylvania State Univ Hershey Med Ctr · R18 · FY2015 · HS

CAREER: Multi-scale Assessment of Biomechanical Alterations in Tricuspid Valves Following Pregnancy

$495,941
Rouzbeh Amini · Northeastern University · · FY2020 · ENG

Epidemiology, Biomarkers and Exposure Assessment of Metals

$495,899
Margaret Rita Karagas · Dartmouth College · P42 · FY2017 · ES

Validation and application of portable particulate device in the UW Twin Registry

$495,858
Edmund Seto · University Of Washington · R33 · FY2019 · ES

Genetic and Environmental Determinants of GPRC6A Regulation of Energy Metabolism Using Genetically Engineered Mice and Systems Biology

$495,854
L Darryl Quarles · University Of Tennessee Health Sci Ctr · R01 · FY2020 · DK

Genetic and Environmental Determinants of GPRC6A Regulation of Energy Metabolism Using Genetically Engineered Mice and Systems Biology

$495,854
Min Pi · University Of Tennessee Health Sci Ctr · R01 · FY2023 · DK

Genetic and Environmental Determinants of GPRC6A Regulation of Energy Metabolism Using Genetically Engineered Mice and Systems Biology

$495,854
L Darryl Quarles · University Of Tennessee Health Sci Ctr · R01 · FY2022 · DK

Genetic and Environmental Determinants of GPRC6A Regulation of Energy Metabolism Using Genetically Engineered Mice and Systems Biology

$495,854
L Darryl Quarles · University Of Tennessee Health Sci Ctr · R01 · FY2021 · DK

Trial of Decision Support to Improve Diabetes Outcomes

$495,844
Randall D Cebul · Case Western Reserve University · R01 · FY2006 · HS

Targeting Scleral Stiffness as a Novel Therapeutic Approach in Glaucoma

$495,843
C Ross Ethier · Georgia Institute Of Technology · R01 · FY2019 · EY

Hepatic stellate cells in NASH fibrosis and HCC

$495,775
Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · DK

Inflammation, long-term diabetes characteristics, and cognitive decline

$495,772
Michal Schnaider Beeri · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · AG

Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II Study

$495,766
Bruce Ovbiagele · Northern California Institute/Res/Edu · R01 · FY2024 · NS

Cerebral Artery Integrity Linked to Brain Injury and Cognition in Congenital Heart Disease

$495,712
Nancy Ann Pike · University Of California Los Angeles · R01 · FY2017 · NR

Angiotensin, Sodium and Genes in Primate Hypertension

$495,704
Southwest Foundation For Biomedical Res · R01 · FY2004 · HL